Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Nov 8;19(11):e0310644. doi: 10.1371/journal.pone.0310644

Locating the evidence for children and young people social prescribing: Where to start? A scoping review protocol

Julie Feather 1,*, Shaun Liverpool 2,3, Eve Allen 2,3, Michael Owen 2,3, Nicola Relph 2,3, Lynsey Roocroft 2,3, Tasneem Patel 2,3, Hayley McKenzie 2,3, Ciaran Murphy 2, Michelle Howarth 2,3
Editor: Apurva Kumar Pandya4
PMCID: PMC11548728  PMID: 39514480

Abstract

It is estimated that disruptions to life caused by the COVID-19 pandemic have led to an increase in the number of children and young people suffering from mental health issues globally. In England one in four children experienced poor mental health in 2022. Social prescribing is gaining traction as a systems-based approach, which builds upon person-centered methods, to refer children and young people with non-clinical mental health issues to appropriate community assets. Recognition of social prescribing benefits for children’s mental health is increasing, yet evidence is limited. Inconsistent terminology and variation of terms used to describe social prescribing practices across the literature hinders understanding and assessment of social prescribing’s impact on children’s mental health. This scoping review thus aims to systematically identify and analyse the various terms, concepts and language used to describe social prescribing with children and young people across the wider health and social care literature base. The scoping review will be undertaken using a six-stage framework which includes: identifying the research question, identifying relevant studies, study selection, charting the data, collating, summarising and reporting the results, and consultation. Electronic databases (MEDLINE, Embase, Cumulative Index to Nursing and Allied Health, PsychInfo, Social Policy Practice, Scopus, Science Direct, Cochrane library and Joanna Briggs), alongside evidence from grey literature, hand search, citation tracking, and use of expert correspondence will be included in the review to ensure published and unpublished literature is captured. Data extraction will be carried out by two reviewers using a predefined form to capture study characteristics, intervention descriptions, outcomes, and key terms used to report social prescribing for children and young people. No formal quality appraisal or risk of bias evaluation will be performed, as this scoping review aims to map and describe the literature. Data will be stored and managed using the Rayaan.ai platform and a critical narrative of the common themes found will be included.

Introduction

In the post COVID-19 era, the need to empower resilience in communities and individuals is key to tackling widening health inequalities. Marmot et al. [1] recommended a cross departmental health inequalities strategy which could lay the foundation for a new social contract. The Hewitt Review [2] also advocates a paradigm shift that promotes health and wellbeing through upstream approaches. Recently, the United Kingdom (UK) National Health Service (NHS) Long Term Plan [3] promoted social prescribing to help reduce tackling health inequalities. According to the Kings Fund [4] “Social prescribing, also sometimes known as community referral, is a means of enabling health [and care] professionals to refer people to a range of local, non-clinical services. The referrals generally, but not exclusively, come from professionals working in primary care settings, for example, GPs or practice nurses”. A global definition, recently developed by Muhl et al. [5 p8] further encapsulates the definition as a concept as being “a means for trusted individuals in clinical and community settings to identify that a person has non-medical, health-related social needs and to subsequently connect them to non-clinical supports and services within the community by co-producing a social prescription—a non-medical prescription, to improve health and well-being and to strengthen community connections”. While the practice of referring individuals into community-based support has a long history, since 2016, social prescribing has been increasingly used as an integrated approach by health professionals to refer children and young people for non-clinical reasons to a link worker to assess what matters to an individual before onward referral to a community-based asset.

Social prescribing is increasingly promoted by policy makers and commissioners as a strengths-based approach to supporting communities and is particularly relevant post COVID-19, where it is recognised to have impacted on children and young people’s mental health [6]. Indeed, one in four children in England now experience poor mental health [7]. A report undertaken by the Children’s Commissioner for England [8] showed that one in nine children aged between 5–19 years had a probable mental health disorder in 2017. This figure increased to one in six in 2019/2020 [6] then to one in four in 2022 [7], leading to a 44% increase in the number of children receiving support from the UK National Health Service (NHS) over just a five-year period. The impact of COVID-19 on children and young people’s mental health is echoed globally. Therefore, the World Health Organisation [9] has called for action on children and young people’s mental health across health systems.

The ‘Are we listening’ report conducted by the Care Quality Commission [10] in the UK highlights the importance of children’s voices in informing mental health support, stating that services are at crisis point. The report highlighted issues with service access, high demand, and long waiting lists, leading children and young people to need more intensive treatments or feel they must be ‘suicidal’ to get an appointment [10]. Children and young people often feel they need to be desperate to access mental health support [10]. Future in Mind [11], The Five Year Forward View for Mental Health [12] and Transforming Children and Young People’s Mental Health Provision: A Green Paper [13], all discuss improving mental health systems for children and young people in the UK. Despite aims to build the mental health workforce, support school mental health teams, and improve service access, daily barriers still impede children and young people from accessing support [14, 15]. Some of these barriers could be alleviated by taking an upstream approach which includes social prescribing.

When considering access to services, General practitioners (GPs) are key in signposting services [16], but face barriers such as time, confidence, lack of resources, lack of providers and long waiting times [14, 16, 17]. The lack of targeted support can lead to children and young people trying to manage or cope in their own way or question the seriousness of their challenges [15, 16]. Additionally, children and young people feel that choice is crucial in accessing support [14, 18]. However, choice can be limited by parents, carers, or teachers who may be guided by other professionals or policies [14]. Empowering children and young people with choice, autonomy, education and support can help them make positive changes and feel secure in their decisions [19]. Lack of understanding and education on mental health issues for young people and where to access support is a significant barrier [14, 16, 18]. Again, a paradigm shift, to an upstream preventative approach, such as social prescribing could provide children and young people with more control and access to treatments without needing a gatekeeper.

Within the UK, Social Prescribing emerged in the General Practice Forward View [20] as an approach that health professionals could use to support patients with a non-clinical need. The premise was to introduce a system that facilitated a structured referral enabling patients to engage with local assets to improve wellbeing. As part of this vision, social prescribing models were introduced, supporting holistic health by linking social care and other support needs. Since this time, and to help tackle the impact of health and social inequalities, the NHS Long Term Plan [3] expanded the ambitions to further improve prevention and early intervention. A range of social prescribing models have been developed as a result and are increasingly becoming more embedded within the integrated care systems.

There is growing evidence supporting the development and evaluation of social prescribing programmes across the lifespan. Foremost, social prescribing has proven to have a positive impact on health and well-being as well as service users’ experience [21]. Similar positive outcomes have been noted for loneliness, quality of life, self-efficacy, and health care utilisation [22]. Among the older adult population, there is a wealth of research highlighting the positive effects of social prescribing on physical and psychosocial outcomes [23], yet the evidence base for children and young people appears to be limited [24].

A recent rapid review undertaken by Hayes et al. [25] reported that there is some emerging evidence indicating benefits of social prescribing for children and young people growing in the past 2 years from no studies to four studies. Whilst this suggests an interest, it also is indicative of the lack of evidence in this area. Variation and lack of consistency in the terms used to describe social prescribing for children and young people across the wider literature could explain the limited evidence available. For example, common terms in this area include ‘social prescribing’, ‘non-medical intervention’, ‘community referral’ [26], ‘community asset’, ‘community-based support’ and ‘Arts on Prescription’ [27]. Additionally, specific interventions or models of social prescribing for children and young people may use different names or descriptors depending on the context of the intervention. For example, arts-based interventions and physical activity programmes delivered to improve children and young peoples’ mental health are often based on the principles of social prescribing yet the term is not explicitly used when reporting on such programmes [27, 28]. The terms and language used to describe social prescribing with children and young people are thus diverse and heterogenous making it difficult to capture the scope of breadth of social prescribing practices for children and young people in the wider literature.

To address this gap, we will undertake a scoping review of the literature using Arksey and O’Malley’s [29] stepped framework which facilitates a systematic approach to assess the breadth of evidence around a broad subject. By conducting a scoping review of all available evidence that refers to any form of social prescribing, with children and young people, we aim to systematically identify and analyse the various terms, concepts, and language used across different studies and contexts. This comprehensive approach will enable us to capture the breadth of literature on social prescribing for children and young people, shedding light on diverse practices and perspectives within the wider health and social care landscape. This scoping review will seek to address the gaps in knowledge and terminology used in social prescribing with children and young people, facilitating more nuanced and informed discussions, and guiding future research and practice in social prescribing for children and young people’s mental health. The scoping review will be conducted in accordance with the Preferred Reporting Items for Scoping Reviews (PRISMA-ScR) [30].

Review questions

  1. How is social prescribing with children and young people (up to 19 years old) to improve mental health and wellbeing described within the evidence base?

  2. What are the key terms used to report social prescribing with children and young people (up to 19 years old) to improve mental health and wellbeing within the evidence base?

Eligibility criteria

Population

The approach to the scoping search will be interactive, as advocated by Brettle and Grant [31]. We will use the Population, Concept, Context (PCC) model to structure search terms [32]. The population under study will include any child or young person up to the age of 19 who has been ‘socially prescribed’ to receive a non-medical/asset-based intervention to improve their mental health or wellbeing.

Concept

The principal concepts of interest in this review are ‘social prescribing’ and ‘mental health or wellbeing’. The review will use Muhl et al’s [5] definition of social prescribing as “a means for trusted individuals in clinical and community settings to identify that a person has non-medical, health-related social needs and to subsequently connect them to non-clinical supports and services within the community by co-producing a social prescription—a non-medical prescription, to improve health and well-being and to strengthen community connections”.

Conceptional conditions for inclusion will include:

  1. There has been a ‘referral’ from a health, care or teaching professional or equivalent.

  2. The individual has been referred for a non-clinical reason.

  3. The referral is to support the child/young person’s mental health.

  4. The range of assets used can vary and will not be standardised.

Evidence sources that explore a concept that does not meet these conditions will be excluded.

Context

The context for this review involves clinical and community settings where trusted individuals, such as health, care, or teaching professionals, identify non-medical, health-related social needs and refer children and young people to non-clinical supports and services within the community. This encompasses primary care settings, community programmes, and other non-clinical environments aimed at improving the mental health and wellbeing of children and young people. We will include studies where referrals are made from these settings to community programmes, even if the individual is later admitted to an inpatient setting. However, we will exclude studies conducted solely in hospitals, emergency departments, inpatient settings, or inpatient mental health settings, as well as studies that do not involve social prescribing in the community context.

Inclusion and exclusion criteria for the review can be found in Table 1.

Table 1. Inclusion and exclusion criteria.

Inclusion Criteria Exclusion Criteria
Post publication from 2016 when the term social prescribing was used consistently
All types of published and unpublished papers that include key terms used to report social prescribing:
    • Social prescribing
    • Non-medical intervention
    • Non pharmaceutical intervention
    • Community referral
    • Referral
    • Non-clinical services
Papers that report on ‘social prescription’ to receive a non-medical/asset-based intervention for children and young people (up to 19 years old) with the aim to improve mental health or wellbeing.
Clinical and community settings including primary care, community programmes and other non-clinical environments.
Primary and secondary studies including qualitative, quantitative, mixed methods and reviews
Papers published in, or able to be translated to English language
Published before 2016
Papers that lack inclusion of key terms
Papers that focus on medical treatments instead of non-medical or asset-based interventions, those that deal with adults rather than children and young people up to 19 years old, or that do not address mental health or wellbeing.
Studies conducted solely in hospitals, emergency departments, inpatient settings, or inpatient mental health settings, as well as studies that do not involve social prescribing in the community context.
Protocol papers, editorials, commentaries and conference abstracts.
Papers that cannot be translated to English Language
Papers where the full text is unavailable

Methods

This protocol has been developed based on Arksey and O’Malley’s [29] framework for scoping reviews which will enable selection of evidence from a range of existing sources. Arksey and O’Malley’s [29] framework follows six key stages which ensure a robust approach to identifying all relevant literature. The stages are: 1. Identifying the research question. 2. Identifying relevant studies. 3. Study selection. 4. Charting the data. 5. Collating, summarising and reporting the results. 6. Consultation. According to Howarth et al. [33] scoping reviews enable the synthesis of evidence on a broad subject area allowing the development of logic models and guidelines to support decision making.

Search strategy

The search strategy aims to locate all types of published and unpublished literature. Electronic searches will include databases MEDLINE, Embase, CINAHL, PsychInfo and Social Policy and Practice. Reviewers will also search Scopus, Science Direct, Cochrane and Joanna Briggs Systematic review databases. An additional search of the grey literature will be undertaken, alongside hand searching the reference lists of relevant papers, citation tracking and use of expert correspondence. Furthermore, a search of the following indicative websites will be undertaken: British Association of Social Work, Association of Child Protection Professionals, Social Work, NHS Digital, NHS Spine, and other credible webpages (e.g. Kings Fund, The Health Foundation). Expert consultation will be sought to ensure data capture of relevant non-published and published literature. We will identify and contact key individuals within Public Health England Children, Young People and Families, Youth Social Prescribing Network, Child Outcomes Research Consortium, Headstart National Evaluation Programme, the Social Prescribing Network, the Social Prescribing Youth Network, the Global Social Prescribing Alliance and the National Academy for Social Prescribing through existing networks and official communication channels. We will ask for their input on relevant literature and feedback on our review. If there is no response, we will reach out to alternative contacts and extend our consultation to additional relevant organisations and networks. To capture the variance in education and referral systems, we will search UK and international literature. The key words that will guide these searches can be found in Table 2.

Table 2. Example search terms.

Population Concept Context
“Child*” OR “Childhood” OR “Adoles*” OR “Young adult*” OR “Young person*” OR “Young people” OR “Youth*” OR “Teen*” “Social prescri*” OR “non-medical intervention*” OR “non pharmaceutical intervention*” OR “community referral*” OR, “referral*” OR
“non-clinical service*” OR “asset-based*” OR “community-based support*”
AND
“Mental health” OR “wellbeing*” OR “anxiety*” OR “depression*” OR “social isolation” OR “social anxiety”
“Community-based support*” OR “primary care*” OR “community program*” OR “non-clinical service*” OR “education*”

Types of evidence sources

A scoping review will enable us to review all types of evidence. This includes primary research studies, systematic and scoping reviews, grey literature including reports, government documents, policy papers and other non-peer reviewed publications and online sources that may provide insights related to the review question. We will only include sources with full text.

Evidence screening and selection

Data will be stored and managed using the Rayaan.ai platform (Rayyan - AI Powered Tool for Systematic Literature Reviews). The titles and abstracts of all located papers will be screened by two separate reviewers and assessed according to predetermined inclusion criteria (see Table 1). Papers meeting the inclusion criteria will be retrieved in full and comprehensively assessed by two reviewers independently. Any conflicts will be resolved by discussion with the wider team. Papers failing to meet the inclusion criteria will be excluded from further consideration.

Data extraction

Two reviewers will extract relevant data from included papers using a data extraction tool (Table 3) designed by the research team. Data extracted will include: (1) bibliographic information including authors, publication year, title, journal or source; (2) study population including age of children and young people and sample size; (3) Aim(s) of study; (4) study setting; (5) study design and data collection methods; (6) type of intervention, programme or service offered to children and young people; (7) key findings and key words used to report social prescribing with children and young people. The data extraction tool may be adapted accordingly as data emerges. Disagreements will be resolved through discussion and, if unresolved, reviewers will seek input from a third reviewer. If needed, the primary author of included studies will be contacted to attain missing data and for clarification of study methods and results. Any changes to the extraction process will be documented in the full review write-up.

Table 3. Data extraction table.

Author name, year of publication, title, and source Study population (age of children and young people, sample size) Aim(s) of study Study setting Study design and data collection methods Intervention/programme/service used to support children and young people social prescribing in mental health (e.g. tools, mechanisms, outcomes used for referral) Key findings/key words used to report social prescribing

Data analysis and presentation

We will analyse and present our findings using both written narratives and tabular summaries. We will use descriptive statistics to quantify the frequency of key terms related to social prescribing. We will use thematic and content analyses to identify common themes and variations in how social prescribing is described across studies. We will provide illustrative quotes to highlight different interpretations of social prescribing. To validate our findings, we will consult with experts in the field as described in the next section of this protocol.

Consultation

In order to ensure our findings are aligned with the wider literature, consultations will be undertaken with key stakeholders. The consultations are designed primarily to inform and validate findings from the review. However, it may be necessary to obtain input at earlier stages to sensitise the review team to issues that may or may not appear in the literature, and to be guided towards relevant studies. Representatives from a range of organisations, including Streetgames, GP services and Social Prescribing Task Network will be consulted. We also aim to capture the views of parents and carers and young people with lived experience of mental health problems based on discussions from patient and public involvement and engagement (PPIE) sessions that members of the research team have previously undertaken. Where possible, PPIE consultations will be integrated into both early and later stages of the review process. Initially, we will engage with a small group of parents, carers and young people to seek early feedback to help shape the reviews focus and search strategy. PPIE members will be identified through existing networks and prior engagement sessions conducted by the research team. Consultations will be conducted individually or in groups, and notes will be taken solely to inform the review process. Following the completion of the review, additional PPIE consultations will be conducted to validate findings and ensure that they align with the experiences of parents, carers and young people. We aim to conduct five to seven semi-structured consultations, lasting 1 hour and involving five to ten participants. Although formal ethics approvals will not be required, the consultation exercises will be guided by established ethical codes of conduct [34]. Ethical considerations, including informed consent and confidentiality, will guide these consultations, ensuring stakeholder input shapes the review process and conclusions.

Supporting information

S1 Checklist. PRISMA-P 2015 checklist.

(DOCX)

pone.0310644.s001.docx (27.8KB, docx)

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The author(s) received no specific funding for this work.

References

Decision Letter 0

Apurva kumar Pandya

9 Jul 2024

PONE-D-24-11234Locating the evidence for children and young people social prescribing: Where to start? A scoping review protocolPLOS ONE

Dear Dr. Feather,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

============================== 

This paper outlines a protocol for a scoping review on social prescribing for mental health conditions among young people. It is well written and provides an important contribution to the literature. There are some methodological details missing from this paper that should be addressed by the authors. There are also grammatical and punctuation errors that require the authors' attention.

Please submit your revised manuscript by Aug 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Apurva kumar Pandya, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments:

This paper outlines a protocol for a scoping review on social prescribing for mental health conditions among young people. It is well written and provides an important contribution to the literature. There are some methodological details missing from this paper which should be addressed by authors. There are also grammatical and punctuation errors that require authors' attention.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overview: This paper outlines a protocol for a scoping review on social prescribing for mental health conditions among young people. It is well written and provides an important contribution to the literature. There are some methodological details missing from this paper which should be addressed by authors.

Abstract and Introduction:

- Line 25: can remove the (‘) from ‘systems-based approach’

- Line 32: Please include in the abstract the type of review that will be conducted (scoping?)

- Line 39-40: I’m not sure what is meant by ‘data extraction will be carried out by two reviewers to identify the scope and depth of MeSH used in the literature…’; MeSH headings are typically a part of the search strategy and not something you would look to during data extraction so it is unclear what is meant by this sentence. Please clarify.

- Line 42-43: Please include an additional line about data synthesis and risk of bias. How will this step be completed? Will you conduct a risk of bias/quality appraisal assessment?

- The introduction section could be shortened to ensure conciseness; I think the 2nd last paragraph could be removed as it seems a bit repetitive

- Line 72-75: please spell out numbers under 10 (or use % if it’s easier to indicate what is meant)

Methods

- Line 173: could you provide a reference for the 0-25 age range? Other criteria for youth in the literature include 0-18- or 0–19-year-olds, so could authors clarify whether age 25 still counts as youth/young person?

- Line 171-174: could authors add more detail about who is and is not included in this study (do they need to have a diagnosed mental health condition? What about things like eating disorders? What about other neurological or intellectual impairments? What if people have multiple conditions? Would you include any gender, age, ethnicity, any country, etc. What about pregnant individuals? People using alcohol or drugs?)

- Line 191-194: This section should only focus on context (ie. Clinical setting/environment), so any details about participants and social prescribing should be removed from this section. Instead, more detail about what contexts are and are not considered for inclusion is needed (e.g., what about hospitals? Emergency departments? Inpatient settings? In-patient mental health settings? Will you consider studies where the individuals are admitted to an inpatient setting but they have been referred to a community program or will you only consider studies that take place in the setting where they were referred to via social prescribing? What about primary care, community programs, etc.). Please add more detail about what settings are in versus out.

- Table 1 should include all the inclusion/exclusion criteria (for PCC, not just for the types of studies)

- Will you consider studies that are not in English but can be translated to English?

- What about study design? Please outline what types of studies you will vs won’t include (reviews? Protcols? Grey literature?)

- Line 219: How will you complete the expert consultation? Do you know individuals in these organizations who are willing to provide input or are you going to reach out and see who responds? What exactly will their role be? What if they don’t respond or cooperate?

- Table 2: Do you have a librarian to help with the search strategy? Based on table 2, there are some notable limitations with the proposed search. For example, authors should use truncation to capture any related/similar terms, such as adoles* to capture adolescent, adolescence, and adolescents. Depending on the database, you should also use MeSH terms to capture certain topics. Please review the search strategy with a librarian and include an example of a search that will be conducted in one of your databases, like CINAHL, and include this in your table 2

- Table 3: some other details to include: study design, age of participants, study setting

- Table 3: Can you clarify what is meant by MeSH terms in this table? What if studies don’t use MeSH terms (this is data-base dependent), or do you mean ‘key words’? I’m not sure this information will be available for every paper so I’m not sure what value it adds. Rather, you might want to consider a deeper analysis into the way that social prescribing is described in studies if you want to understand how it is reported. Is there a social prescribing framework or definition you could use to inform this?

- Line 261: should say ‘synthesize’ not ‘synthesis’

- Line 261-264: See previous comments about MeSH terms

- Line 261-264: more detail about the synthesis approach is needed; Will authors report findings in writing, in tables, both? Are there other ways to describe how social prescribing is outlined across papers? How will you determine whether studies truly used social prescribing or not?

- Consultation: I like the inclusion of patients/families here! Can you include detail about when this step will take place? Will stakeholders be identified at the outset or will consultations only happen after the review is complete and findings shared with these groups?

Reviewer #2: This paper is a protocol of a scoping review on social prescribing for the mental health of young people and children aged up to 25 years old. The manuscript is well written and the protocol for the scoping review is thorough and technically sound. The rationale for the study is clear and valid. The methodology is reported in detail. The additional step of consultation is excellent and adds to the validity of the study.

Some aspects of the protocol that can be made better:

1. While the methods sections is extremely well written, succinct and clear, I I feel that the Introduction section of the paper could be improved, especially in making it succinct and clearer. For example, on one hand, paragraph 3 and paragraph 4 (paragraphs about young people’s mental health) can be considerably shortened. On the other hand, the paragraphs specifically talking about social prescribing can be improved – for example, for readers unfamiliar with the concept of social prescribing, a brief overview of history of the concept across different countries would be important. Currently, the manuscript gives the impression that social prescribing emerged only around 2016. It would be important to clarify that while the term is relatively new the practice is much older.

2. Specific details on the planned consultation would be useful including how many consultations, of what duration, with how many people, how will they be structured, how will they inform the protocol, how will they inform the review. While it makes sense that an IRB approval may not be required for the consultation, it is important to outline the ethical considerations for these consultations.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Nov 8;19(11):e0310644. doi: 10.1371/journal.pone.0310644.r002

Author response to Decision Letter 0


16 Aug 2024

Dear Reviewers,

Thank you for your reply regarding our manuscript PONE-D-24-11234 entitled “Locating the evidence for children and young people social prescribing: Where to start? A scoping review protocol”.

We would like to thank both reviewers for your valuable feedback and observations which have been used to improve our manuscript. We have revised and modified the manuscript in line with your comments.

The table below provides a point-by-point response to the reviewers’ comments. Revisions to the manuscript have been highlighted using the track changes mode in MS Word.

Reviewers’ comments Authors’ response

Reviewer 1

Abstract:

- Line 25: can remove the (‘) from ‘systems-based approach’

- Line 32: Please include in the abstract the type of review that will be conducted (scoping?)

- Line 39-40: I’m not sure what is meant by ‘data extraction will be carried out by two reviewers to identify the scope and depth of MeSH used in the literature…’; MeSH headings are typically a part of the search strategy and not something you would look to during data extraction so it is unclear what is meant by this sentence. Please clarify.

- Line 42-43: Please include an additional line about data synthesis and risk of bias. How will this step be completed? Will you conduct a risk of bias/quality appraisal assessment? Many thanks for your helpful suggestions on how to improve our abstract.

Response:

We have removed (‘) from ‘systems-based approach’.

We have also added ‘scoping review’ to identify the type of review we will be conducting.

Line 39-40 has been amended to: Data extraction will be carried out by two reviewers using a predefined form to capture study characteristics, intervention descriptions, outcomes, and terminology related to social prescribing for children and young people.

Line 42-43: We have added the following sentence - No formal quality appraisal or risk of bias evaluation will be performed, as this scoping review aims to map and describe the literature. This is in line with methodological guidance on the conduct of scoping reviews (see Arksey and O’Malley, 2005 and JBI manual for evidence synthesis, 2024, https://jbi-global-wiki.refined.site/space/MANUAL/355862497/10.+Scoping+reviews).

Introduction:

- The introduction section could be shortened to ensure conciseness; I think the 2nd last paragraph could be removed as it seems a bit repetitive

- Line 72-75: please spell out numbers under 10 (or use % if it’s easier to indicate what is meant)

Response:

Many thanks for your helpful suggestions.

We have shortened the introduction section by removing the 2nd to last paragraph.

We have spelt numbers under 10 out throughout our manuscript.

Methods:

- Line 173: could you provide a reference for the 0-25 age range? Other criteria for youth in the literature include 0-18- or 0–19-year-olds, so could authors clarify whether age 25 still counts as youth/young person?

- Line 171-174: could authors add more detail about who is and is not included in this study (do they need to have a diagnosed mental health condition? What about things like eating disorders? What about other neurological or intellectual impairments? What if people have multiple conditions? Would you include any gender, age, ethnicity, any country, etc. What about pregnant individuals? People using alcohol or drugs?)

- Line 191-194: This section should only focus on context (ie. Clinical setting/environment), so any details about participants and social prescribing should be removed from this section. Instead, more detail about what contexts are and are not considered for inclusion is needed (e.g., what about hospitals? Emergency departments? Inpatient settings? In-patient mental health settings? Will you consider studies where the individuals are admitted to an inpatient setting but they have been referred to a community program or will you only consider studies that take place in the setting where they were referred to via social prescribing? What about primary care, community programs, etc.). Please add more detail about what settings are in versus out.

- Table 1 should include all the inclusion/exclusion criteria (for PCC, not just for the types of studies)

- Will you consider studies that are not in English but can be translated to English?

- What about study design? Please outline what types of studies you will vs won’t include (reviews? Protocols? Grey literature?)

- Line 219: How will you complete the expert consultation? Do you know individuals in these organizations who are willing to provide input or are you going to reach out and see who responds? What exactly will their role be? What if they don’t respond or cooperate?

- Table 2: Do you have a librarian to help with the search strategy? Based on table 2, there are some notable limitations with the proposed search. For example, authors should use truncation to capture any related/similar terms, such as adoles* to capture adolescent, adolescence, and adolescents. Depending on the database, you should also use MeSH terms to capture certain topics. Please review the search strategy with a librarian and include an example of a search that will be conducted in one of your databases, like CINAHL, and include this in your table 2

- Table 3: some other details to include: study design, age of participants, study setting

- Table 3: Can you clarify what is meant by MeSH terms in this table? What if studies don’t use MeSH terms (this is data-base dependent), or do you mean ‘key words’? I’m not sure this information will be available for every paper so I’m not sure what value it adds. Rather, you might want to consider a deeper analysis into the way that social prescribing is described in studies if you want to understand how it is reported. Is there a social prescribing framework or definition you could use to inform this?

- Line 261: should say ‘synthesize’ not ‘synthesis’

- Line 261-264: See previous comments about MeSH terms

- Line 261-264: more detail about the synthesis approach is needed; Will authors report findings in writing, in tables, both? Are there other ways to describe how social prescribing is outlined across papers? How will you determine whether studies truly used social prescribing or not?

- Consultation: I like the inclusion of patients/families here! Can you include detail about when this step will take place? Will stakeholders be identified at the outset or will consultations only happen after the review is complete and findings shared with these groups?

Response:

Thank you for your very helpful comments on our methods section. We have made the following changes as recommended by reviewers to strengthen our methods section:

Line 173 – Thank you for raising this important point. We have changed our age criteria to 0-19 which is more consistent with the age range for CYP reported in the social prescribing literature.

Line 171-174 (Population) – We have changed the wording slightly to reflect that ANY child or young person (up to 19 years) will be included in the review on the condition that they have been ‘socially prescribed’ to receive a non-medical/asset-based intervention. This is regardless of diagnosed mental health conditions, specific conditions like eating disorders, neurological or intellectual impairments, multiple conditions, gender, age, ethnicity, country, pregnancy status, or substance use.

Line 191-194 (Context) – We have amended this paragraph and removed information relating to participants and social prescribing. We have given details of which settings/environments will be included and which will be excluded.

Table 1 has now been updated to ensure all PCC inclusion and exclusion criteria are included.

Yes. We have changed the inclusion and exclusion criteria relating to this in table 1. We will include papers published in, or able to be translated to English Language.

We have added information on the types of study designs that will be included and excluded in Table 1: Inclusion and exclusion criteria. We will include empirical studies only including qualitative, quantitative or mixed methods design. We will exclude protocol papers, reviews, editorials, commentaries and conference abstracts.

We have amended the section on expert consultation to include details on how we will contact experts, what their role will be and what our contingency plan is if they do not respond.

Thank you for your valuable feedback. While we are currently unable to work with a librarian, we have taken your suggestions into account and made updates to our search strategy to enhance its effectiveness. Table 2 has been updated. We have re-structured our search terms in line with the Population, Concept, Context (PCC) model. We have incorporated truncation and related terms into our search strategy. We will use appropriate MeSH terms where applicable to ensure comprehensive coverage of topics. For example, in databases like CINAHL we will include MeSH terms relevant to social prescribing and non-clinical interventions. We believe these adjustments address the reviewer’s concerns and will improve the robustness of our search strategy.

We have updated table 3 to include study design, study population and study setting.

We have removed reference to MeSH terms. We have amended the final column on findings to also include information on the concepts used to describe social prescribing for children and young people in the literature. We will use Muhl’s definition of social prescribing as described on page 9 to inform this.

The word synthesize has now been used.

We take on board your feedback that not all studies will use MeSH terms or that these might not be uniformly available. Instead of relying on MeSH terms we will instead identify and use key words and phrases that researchers use within the literature to report or describe social prescribing with children and young people. We will use Muhl’s definition of social prescribing as described on page 9 to guide us. We have replaced reference to MeSH terms with key terms throughout our manuscript.

We have amended the section on data analysis and presentation taking into account reviewer comments. We have described in more detail how data will be analysed and how our findings will be presented.

We have updated the section on consultations to provide information on how PPIE members will be identified and at what stages we will undertake PPIE consultations.

Reviewer 2

Introduction:

While the methods sections is extremely well written, succinct and clear, I feel that the Introduction section of the paper could be improved, especially in making it succinct and clearer. For example, on one hand, paragraph 3 and paragraph 4 (paragraphs about young people’s mental health) can be considerably shortened. On the other hand, the paragraphs specifically talking about social prescribing can be improved – for example, for readers unfamiliar with the concept of social prescribing, a brief overview of history of the concept across different countries would be important. Currently, the manuscript gives the impression that social prescribing emerged only around 2016. It would be important to clarify that while the term is relatively new the practice is much older.

Response:

Thank you for your valuable comments. We have reviewed our introduction and tried where possible to shorten this, removing sentences and words that are not required. Paragraphs 3 and 4 have been shortened considerably.

We have further added a short paragraph to provide more context for readers on the history of social prescribing (see lines 129-137).

We have changed the wording of the sentence which states that social prescribing only emerged around 2016 to instead highlight that the practice of referring individuals into community-based support has a long history.

Consultations:

Specific details on the planned consultation would be useful including how many consultations, of what duration, with how many people, how will they be structured, how will they inform the protocol, how will they inform the review. While it makes sense that an IRB approval may not be required for the consultation, it is important to outline the ethical considerations for these consultations.

Response:

Thank you for your very helpful comments. As stated above we have added more detail to the consultations section to include more information on how many consultations will be completed, for how long, how many participants and how these will be used to inform the review. We have also added a sentence which outlines the ethical considerations.

I look forward to hearing from you regarding our submission. I am happy to respond to any further questions and comments that you may have.

Yours Sincerely,

Author

Attachment

Submitted filename: Response to Reviewers.docx

pone.0310644.s002.docx (24.9KB, docx)

Decision Letter 1

Apurva kumar Pandya

5 Sep 2024

Locating the evidence for children and young people social prescribing: Where to start? A scoping review protocol

PONE-D-24-11234R1

Dear Dr. Feather,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Apurva kumar Pandya, PhD

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: All earlier comments have been addressed to reasonable satisfaction and the paper is recommended for publication.

Reviewer #3: 1) Abstract is well-written.

2) Introduction is well written, but there is a scope to make it more concise.

3) Methodology is well structured addressing all the comments provided by the reviewers initially.

4) Data extraction section is well-written.

The previous reviewers' comments have been addressed and incorporated correctly.

Reviewer #4: Introduction and Rationale:

The introduction emphasizes the increasing acknowledgment of social prescribing as a valuable approach for addressing mental health issues in children and young people. This section is well-crafted and effectively clarifies the importance of social prescribing as a tool in the mental health landscape, particularly for younger populations. By connecting these points, the introduction lays a strong foundation for understanding the relevance and necessity of integrating social prescribing into mental health care strategies for children and adolescents.

Research Gaps and Justification:

The rationale for utilizing a scoping review methodology is well-founded and thoroughly explained. This approach is justified by the need to map out the existing research landscape, identify gaps, and provide a comprehensive overview of the current knowledge on the topic.

Methodology:

The method is clearly articulated, with each step described in a detailed and understandable manner. The clarity and precision with which the methodology is presented contribute to the overall robustness and credibility of the review, making it a valuable tool for systematically mapping the existing research landscape. The adoption of the six-stage framework for the scoping review is both highly appropriate and skillfully executed. This well-established framework guides the review process through each critical phase, from defining the research question to collating and summarizing the data, ensuring a comprehensive exploration of the topic.

Overall Structure:

The paper is thoughtfully organized and highly readable, with a clear and logical flow that guides the reader through the content seamlessly. Each section is well-defined and contributes meaningfully to the overall narrative, ensuring that the paper is easy to follow. The structure effectively supports the presentation of the research, making complex information accessible and engaging. The coherence and clarity of the organization enhance the reader's understanding, allowing the key points and arguments to be conveyed with impact.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Harikeerthan Raghuram

Reviewer #3: No

Reviewer #4: No

**********

Acceptance letter

Apurva kumar Pandya

10 Sep 2024

PONE-D-24-11234R1

PLOS ONE

Dear Dr. Feather,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Apurva kumar Pandya

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA-P 2015 checklist.

    (DOCX)

    pone.0310644.s001.docx (27.8KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0310644.s002.docx (24.9KB, docx)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES